Licence Type

Need Help?
img
img

Description:

In the last several years, global market of Cutaneous Fibrosis Treatment developed rapidly, with an average growth rate of 5.69% during 2014 to 2018. In 2018, global revenue of Cutaneous Fibrosis Treatment is nearly 475 USD.

There is no approved therapy for the cutaneous fibrosis treatment. Not a single drug has been approved for the cutaneous fibrosis treatment, which has led drug manufacturers to evaluate the efficacy and action of various drugs for the cutaneous fibrosis treatment. Various companies are evaluating different molecules for the cutaneous fibrosis treatment.

For example, miRagen Therapeutics, Inc. is evaluating the REMLARSEN (MRG-201) for the cutaneous fibrosis treatment, and it is currently in the Phase 2 of clinical trials. Various other companies are also focusing on diseases with high unmet needs. The largely unmet needs in the cutaneous fibrosis treatment further underlines the untapped treatment-wise as well as revenue generation-wise potential

This report focuses on the global Cutaneous Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cutaneous Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study

AbbVie

Bayer

Merck

Bristol-Myers Squibb

Sanofi

Boehringer Ingelheim

Roche

GlaxoSmithKline

Pfizer

Novartis

LEO Pharma

Actelion

Market segment by Type, the product can be split into

Immunotherapy

Corticosteroids

Anti-Fibrotic Drugs

Immunoglobulins

Market segment by Application, split into

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Market segment by Regions/Countries, this report covers

North America

Europe

China

Japan

Southeast Asia

India

Central & South America

RoW

Table of content:

1 Report Overview 1

1.1 Study Scope 1

1.2 Key Market Segments 1

1.3 Players Covered 2

1.4 Market Analysis by Type 3

1.4.1 Global Cutaneous Fibrosis Treatment Market Size Growth Rate by Type (2019-2025) 3

1.4.2 Immunotherapy 5

1.4.3 Corticosteroids 5

1.4.4 Anti-Fibrotic Drugs 6

1.4.5 Immunoglobulins 6

1.5 Market by Application 6

1.5.1 Global Cutaneous Fibrosis Treatment Market Share by Application (2019-2025) 7

1.5.2 Hospitals Pharmacies 8

1.5.3 Retail Pharmacies 9

1.5.4 Online Pharmacies 9

1.6 Study Objectives 10

1.7 Years Considered 10

2 Global Growth Trends 11

2.1 Global Cutaneous Fibrosis Treatment Market Size 11

2.2 Cutaneous Fibrosis Treatment Growth Trends by Regions 12

2.2.1 Cutaneous Fibrosis Treatment Market Size by Regions (2019-2025) 12

2.2.2 Cutaneous Fibrosis Treatment Market Share by Regions (2014-2019) 12

2.3 Industry Trends 14

2.3.1 Market Top Trends 14

2.3.2 Market Drivers 15

2.3.3 Market Challenges 15

2.3.4 Porter’s Five Forces Analysis 15

3 Market Share by Key Players 17

3.1 Cutaneous Fibrosis Treatment Market Size by Players 17

3.1.1 Global Cutaneous Fibrosis Treatment Revenue by Players (2018-2019) 17

3.1.2 Global Cutaneous Fibrosis Treatment Revenue Market Share by Players (2018-2019) 18

3.1.3 Global Cutaneous Fibrosis Treatment Market Concentration Ratio (CR5) 19

3.2 Cutaneous Fibrosis Treatment Key Players Headquarters and Established Year 20

3.3 Mergers & Acquisitions, Expansion Plans 20

4 Breakdown Data by Type and Application 24

4.1 Global Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) 24

4.2 Global Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) 25

5 North America 28

5.1 North America Cutaneous Fibrosis Treatment Market (2014-2019) 28

5.2 Cutaneous Fibrosis Treatment Key Players in North America 28

5.3 North America Cutaneous Fibrosis Treatment Market Size by Type 29

5.4 North America Cutaneous Fibrosis Treatment Market Size by Application 30

6 Europe 31

6.1 Europe Cutaneous Fibrosis Treatment Market (2014-2019) 31

6.2 Cutaneous Fibrosis Treatment Key Players in Europe 31

6.3 Europe Cutaneous Fibrosis Treatment Market Size by Type 32

6.4 Europe Cutaneous Fibrosis Treatment Market Size by Application 33

7 China 34

7.1 China Cutaneous Fibrosis Treatment Market (2014-2019) 34

7.2 Cutaneous Fibrosis Treatment Key Players in China 34

7.3 China Cutaneous Fibrosis Treatment Market Size by Type 35

7.4 China Cutaneous Fibrosis Treatment Market Size by Application 36

8 Japan 37

8.1 Japan Cutaneous Fibrosis Treatment Market (2014-2019) 37

8.2 Cutaneous Fibrosis Treatment Key Players in Japan 37

8.3 Japan Cutaneous Fibrosis Treatment Market Size by Type 38

8.4 Japan Cutaneous Fibrosis Treatment Market Size by Application 39

9 Southeast Asia 40

9.1 Southeast Asia Cutaneous Fibrosis Treatment Market (2014-2019) 40

9.2 Cutaneous Fibrosis Treatment Key Players in Southeast Asia 40

9.3 Southeast Asia Cutaneous Fibrosis Treatment Market Size by Type 41

9.4 Southeast Asia Cutaneous Fibrosis Treatment Market Size by Application 42

10 India 43

10.1 India Cutaneous Fibrosis Treatment Market (2014-2019) 43

10.2 Cutaneous Fibrosis Treatment Key Players in India 43

10.3 India Cutaneous Fibrosis Treatment Market Size by Type 44

10.4 India Cutaneous Fibrosis Treatment Market Size by Application 45

11 Central & South America 46

11.1 Central & South America Cutaneous Fibrosis Treatment Market (2014-2019) 46

11.2 Cutaneous Fibrosis Treatment Key Players in Central & South America 46

11.3 Central & South America Cutaneous Fibrosis Treatment Market Size by Type 47

11.4 Central & South America Cutaneous Fibrosis Treatment Market Size by Application 48

12 Analysis of Cutaneous Fibrosis Treatment Industry Key Manufacturers 49

12.1 AbbVie 49

12.1.1 Company Profile 49

12.1.2 Product Information 50

12.1.3 Revenue, Gross Margin and Revenue Market Share 51

12.2 Bayer 51

12.2.1 Company Profile 51

12.2.2 Product Information 52

12.2.3 Revenue, Gross Margin and Revenue Market Share 53

12.3 Merck 53

12.3.1 Company Profile 53

12.3.2 Product Information 54

12.3.3 Revenue, Gross Margin and Revenue Market Share 54

12.4 Bristol-Myers Squibb 55

12.4.1 Company Profile 55

12.4.2 Product Information 55

12.4.3 Revenue, Gross Margin and Revenue Market Share 56

12.5 Sanofi 57

12.5.1 Company Profile 57

12.5.2 Product Information 58

12.5.3 Revenue, Gross Margin and Revenue Market Share 58

12.6 Boehringer Ingelheim 58

12.6.1 Company Profile 58

12.6.2 Product Information 59

12.6.3 Revenue, Gross Margin and Revenue Market Share 60

12.7 Roche 60

12.7.1 Company Profile 60

12.7.2 Product Information 61

12.7.3 Revenue, Gross Margin and Revenue Market Share 61

12.8 GlaxoSmithKline 62

12.8.1 Company Profile 62

12.8.2 Product Information 63

12.8.3 Revenue, Gross Margin and Revenue Market Share 63

12.9 Pfizer 64

12.9.1 Company Profile 64

12.9.2 Product Information 65

12.9.3 Revenue, Gross Margin and Revenue Market Share 66

12.10 Novartis 66

12.10.1 Company Profile 66

12.10.2 Product Information 67

12.10.3 Revenue, Gross Margin and Revenue Market Share 67

12.11 LEO Pharma 68

12.11.1 Company Profile 68

12.11.2 Product Information 69

12.11.3 Revenue, Gross Margin and Revenue Market Share 69

12.12 Actelion 70

12.12.1 Company Profile 70

12.12.2 Product Information 70

12.12.3 Revenue, Gross Margin and Revenue Market Share 71

12.13 inStem 72

12.13.1 Company Profile 72

12.13.2 Product Information 73

12.14 Miragen Therapeutics 74

12.14.1 Company Profile 74

12.14.2 Product Information 75

12.15 Corbus Pharmaceuticals 76

12.15.1 Company Profile 76

12.15.2 Product Information 78

12.16 Fibrocell Science 78

12.16.1 Company Profile 78

12.16.2 Product Information 79

13 Market Forecast 2019-2025 81

13.1 Market Size Forecast by Regions 81

13.2 North America 83

13.3 Europe 84

13.4 China 85

13.5 Japan 86

13.6 Southeast Asia 87

13.7 India 88

13.8 Central & South America 89

13.9 Market Size Forecast by Product (2019-2025) 89

13.10 Market Size Forecast by Application (2019-2025) 91

14 Analyst's Viewpoints/Conclusions 93

15 Appendix 94

15.1 Research Methodology 94

15.1.1 Methodology/Research Approach 94

15.1.2 Data Source 98

15.2 Disclaimer 100

15.3 Author Details 101

Table of Figures:

Table Cutaneous Fibrosis Treatment Key Market Segments 1

Table Cutaneous Fibrosis Treatment Key Players Covered in 2018 and 2019 2

Table Global Cutaneous Fibrosis Treatment Market Size Growth Rate by Type (2019-2025) (Million US$) 3

Figure Global Cutaneous Fibrosis Treatment Market Share by Type in 2018 4

Figure Global Cutaneous Fibrosis Treatment Market Share by Type in 2025 4

Figure Corticosteroids Features 5

Figure Anti-Fibrotic Drugs Features 6

Figure Immunoglobulins Features 6

Table Global Cutaneous Fibrosis Treatment Market Size Growth by Application (2019-2025) (Million US$) 7

Figure Global Cutaneous Fibrosis Treatment Market Share by Application in 2018 7

Figure Global Cutaneous Fibrosis Treatment Market Share by Application in 2025 8

Figure Hospitals Pharmacies Case Studies 8

Figure Retail Pharmacies Case Studies 9

Figure Online Pharmacies Case Studies 9

Figure Cutaneous Fibrosis Treatment Report Years Considered 10

Figure Global Cutaneous Fibrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$) 11

Table Global Cutaneous Fibrosis Treatment Market Size by Regions 2019-2025 (Million US$) 12

Table Global Cutaneous Fibrosis Treatment Market Size by Regions 2014-2019 (Million US$) 12

Table Global Cutaneous Fibrosis Treatment Market Share by Regions 2014-2019 13

Figure Global Cutaneous Fibrosis Treatment Market Share by Regions 2014-2019 13

Figure Global Cutaneous Fibrosis Treatment Market Share by Regions 2018 14

Table Market Top Trends 14

Table Key Drivers: Impact Analysis (2019-2025) 15

Table Key Challenges 15

Figure Porter's Five Forces Analysis 16

Table Global Cutaneous Fibrosis Treatment Revenue by Players (2018-2019) (Million US$) 17

Table Global Cutaneous Fibrosis Treatment Market Share by Players (2018-2019) 18

Figure Global Cutaneous Fibrosis Treatment Market Share by Players in 2018 19

Table Global Cutaneous Fibrosis Treatment Manufacturers Market Concentration Ratio (CR5) 19

Table Key Players Headquarters and Established Year 20

Table Mergers & Acquisitions, Expansion Plans 20

Table Global Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 24

Table Global Cutaneous Fibrosis Treatment Market Size Share by Type (2014-2019) 24

Figure Global Cutaneous Fibrosis Treatment Market Size Market Share by Type (2014-2019) 25

Table Global Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 25

Table Global Cutaneous Fibrosis Treatment Market Size Share by Application (2014-2019) 25

Figure Global Cutaneous Fibrosis Treatment Market Size Market Share by Application (2014-2019) 26

Figure Global Cutaneous Fibrosis Treatment Revenue Market Share by Application in 2018 27

Figure North America Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 28

Table North America Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 28

Table North America Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 29

Table North America Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 29

Table North America Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 30

Table North America Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 30

Table North America Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 30

Figure Europe Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 31

Table Europe Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 31

Table Europe Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 32

Table Europe Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 32

Table Europe Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 33

Table Europe Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 33

Table Europe Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 33

Figure China Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 34

Table China Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 34

Table China Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 35

Table China Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 35

Table China Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 36

Table China Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 36

Table China Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 36

Figure Japan Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 37

Table Japan Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 37

Table Japan Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 38

Table Japan Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 38

Table Japan Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 39

Table Japan Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 39

Table Japan Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 39

Figure Southeast Asia Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 40

Table Southeast Asia Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 40

Table Southeast Asia Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 41

Table Southeast Asia Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 41

Table Southeast Asia Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 42

Table Southeast Asia Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 42

Table Southeast Asia Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 42

Figure India Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 43

Table India Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 43

Table India Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 44

Table India Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 44

Table India Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 45

Table India Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 45

Table India Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 45

Figure Central & South America Cutaneous Fibrosis Treatment Market Size 2014-2019 (Million US$) 46

Table Central & South America Key Players Cutaneous Fibrosis Treatment Revenue (2018-2019) (Million US$) 46

Table Central & South America Key Players Cutaneous Fibrosis Treatment Market Share (2018-2019) 47

Table Central & South America Cutaneous Fibrosis Treatment Market Size by Type (2014-2019) (Million US$) 47

Table Central & South America Cutaneous Fibrosis Treatment Market Share by Type (2014-2019) 48

Table Central & South America Cutaneous Fibrosis Treatment Market Size by Application (2014-2019) (Million US$) 48

Table Central & South America Cutaneous Fibrosis Treatment Market Share by Application (2014-2019) 48

Table AbbVie Company Profile 49

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of AbbVie 2018-2019 51

Table Bayer Company Profile 51

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Bayer 2018-2019 53

Table Merck Company Profile 53

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Merck 2018-2019 54

Table Bristol-Myers Squibb Company Profile 55

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Bristol-Myers Squibb 2018-2019 56

Table Sanofi Company Profile 57

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Sanofi 2018-2019 58

Table Boehringer Ingelheim Company Profile 58

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Boehringer Ingelheim 2018-2019 60

Table Roche Company Profile 60

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Roche 2018-2019 61

Table GlaxoSmithKline Company Profile 62

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of GlaxoSmithKline 2018-2019 63

Table Pfizer Company Profile 64

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Pfizer 2018-2019 66

Table Novartis Company Profile 66

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Novartis 2018-2019 67

Table LEO Pharma Company Profile 68

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of LEO Pharma 2018-2019 69

Table Actelion Company Profile 70

Table Cutaneous Fibrosis Treatment Revenue (M USD), Gross Margin and Revenue Market Share of Actelion 2018-2019 71

Table inStem Company Profile 72

Table Miragen Therapeutics Company Profile 74

Picture Miragen Therapeutics Product Pipeline 76

Table Corbus Pharmaceuticals Company Profile 76

Picture Corbus Pharmaceuticals Product Pipeline 78

Table Fibrocell Science Company Profile 78

Table Global Cutaneous Fibrosis Treatment Market Size by Regions (Million US$) 2019-2025 81

Figure Global Cutaneous Fibrosis Treatment Market Size Share by Regions (2019-2025) 81

Figure Global Cutaneous Fibrosis Treatment Market Size Share by Regions in 2025 82

Figure North America Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 83

Figure Europe Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 84

Figure China Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 85

Figure Japan Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 86

Figure Southeast Asia Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 87

Figure India Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 88

Figure Central & South America Cutaneous Fibrosis Treatment Market Size Forecast (2019-2025) (Million USD) 89

Table Global Cutaneous Fibrosis Treatment Market Size by Product (2019-2025) (Million USD) 89

Figure Global Cutaneous Fibrosis Treatment Market Size by Product (2019-2025) 90

Figure Global Cutaneous Fibrosis Treatment Market Size by Product in 2025 90

Table Global Cutaneous Fibrosis Treatment Market Size by Application (2019-2025) (Million USD) 91

Figure Global Cutaneous Fibrosis Treatment Market Size Share by Application (2019-2025) 91

Figure Global Cutaneous Fibrosis Treatment Market Size by Application in 2025 92

Table Research Programs/Design for This Report 94

Figure Bottom-up and Top-down Approaches for This Report 96

Figure Data Triangulation 97

Figure Key Executives Interviewed 98

Table Key Data Information from Secondary Sources 99

Table Key Data Information from Primary Sources 99

Related Reports

  • Global Monoamine Oxidase-B Market Insights, Forecast to 2028

  • Global Carbapenem Antibiotics Market Insights, Forecast to 2028

  • Global Artesunate for Malaria Market Insights, Forecast to 2028

  • Global Riostamycin Sulfate for Injection Market Insights, Forecast to 2028

  • Global Compound Ammonium Glycyrrhetate S for Injection Market Insights, Forecast to 2028

  • Global Compound Glycyrrhizin Injection Market Insights, Forecast to 2028

  • Global Ropivacaine Mesylate for Injection Market Insights, Forecast to 2028

  • Global Propacetamol Hydrochloride for Injection Market Insights, Forecast to 2028

Why Purchase this Report?

The report offers a detailed, broad overview of the entire Global Cutaneous Fibrosis Treatment Market landscape to reveal how the most noteworthy trends are unfolding and doors to new opportunities are unlocking. The overview allows exploring what the consumers are readily willing to spend on, which demographics are likely to be forming the key consumer clusters, etc.

Purchase this report now and win an instant access to the most exclusive and actionable insights that are drawn from an exhaustive analysis of industry and its key sectors with the best approach adopted. The insights into the key facets of Global Cutaneous Fibrosis Treatment market accelerate the process of identifying profitable industry trends and arrive at the right decisions.

The report promises to deliver never-before-seen consumer data that would eventually be a chief aid in benchmarking against industry leaders, their pricing strategies, and other developmental moves. Apart from the market size information, the report has it all to aid businesses in performing effective PEST, SWOT, and STEER analysis.

The report aids in identifying the most profitable industry trends that are worth investing in and simultaneously, identify the existing opportunities as well as threats to business in both short and long term. A detailed assessment of the competitive landscape unleashes market shares of major companies along with their strategic developments that make them have an edge over others.

There have been several regulatory entities as well as governments relying on the information research and published by QY Research. Thousands of our clients have been relying on data and insights published by us to stay abreast with the most recent industry trends. The report warrants thoroughly researched, dependable information that eventually leads to better, faster business decisions.

©2007-2026 QY Research All Rights Reserved.